Back to WELLINGTON MANAGEMENT GROUP LLP WELLINGTON MANAGEMENT GROUP LLP

MDGLMDGL
Showing 8 of 13 quarters

Position history for WELLINGTON MANAGEMENT GROUP LLPWELLINGTON MANAGEMENT GROUP LLP's holdings in MADRIGAL PHARMACEUTICALS INC

WELLINGTON MANAGEMENT GROUP LLP holds 825,714 shares of MDGL (MADRIGAL PHARMACEUTICALS INC), worth $443.4M as of 2026-Q2. The position was increased (+18.8% shares). MDGL represents 0.1% of WELLINGTON MANAGEMENT GROUP LLP's portfolio.

Current Value

$443.4M

Current Shares

825,714

Total Value Change

+$441.5M

Total Shares Change

+816,683

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
825,714
+18.8%
$443.4M0.1%$536.95
37
2026-Q1
Increased
694,958
+50.6%
$363.8M0.1%$425.85
43
2025-Q4
Increased
461,402
+14.1%
$268.7M0.0%$583.73
35
2025-Q3
Increased
404,455
+5381.2%
$185.5M0.0%$443.10
49
2025-Q2
Decreased
7,379
-3.3%
$2.2M0.0%$300.75
0
2025-Q1
Decreased
7,628
-6.7%
$2.5M0.0%$327.87
0
2024-Q4
Decreased
8,172
-9.5%
$2.5M0.0%$311.62
0
2024-Q3
New
9,031
-
$1.9M0.0%$212.43
36

Other major holders of MDGL: BAKER BROS. ADVISORS LP, RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used